Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-25-057815

Director acquired 1,045 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HENNEMAN JOHN B III Director 2025-06-05 Grant or award +1,045 10,229 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
HENNEMAN JOHN B III Director 2025-06-05 Grant or award · Stock Options (Right to Buy) +4,185 4,185 D: show line 2 in the form
Loading xslF345X05/tm2517366-5_4seq1.xml…